Latest Insider Transactions at Outset Medical, Inc. (OM)
This section provides a real-time view of insider transactions for Outset Medical, Inc. (OM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Outset Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Outset Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2021
|
Rebecca Chambers Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,727
-30.49%
|
$819,623
$49.64 P/Share
|
|
Mar 25
2021
|
Rebecca Chambers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,727
+35.55%
|
$100,362
$6.25 P/Share
|
|
Mar 23
2021
|
Andrea Lynn Saia Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,043
+50.0%
|
-
|
|
Mar 18
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-9.8%
|
$168,000
$48.17 P/Share
|
|
Mar 18
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.15%
|
$31,500
$9.48 P/Share
|
|
Mar 15
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,255
+47.14%
|
-
|
|
Mar 15
2021
|
Rebecca Chambers Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,597
+50.0%
|
-
|
|
Mar 15
2021
|
John L. Brottem General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
11,169
+43.22%
|
-
|
|
Mar 15
2021
|
Leslie Trigg Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
87,412
+16.01%
|
-
|
|
Jan 08
2021
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,383
+50.0%
|
-
|
|
Jan 05
2021
|
Warburg Pincus X, L.P. |
SELL
Open market or private sale
|
Indirect |
552,934
-10.46%
|
$27,646,700
$50.35 P/Share
|
|
Jan 05
2021
|
Warburg Pincus LLC |
SELL
Open market or private sale
|
Indirect |
552,934
-10.46%
|
$27,646,700
$50.35 P/Share
|
|
Dec 07
2020
|
Warburg Pincus X, L.P. |
SELL
Open market or private sale
|
Indirect |
3,686,225
-41.09%
|
$184,311,250
$50.35 P/Share
|
|
Dec 07
2020
|
Warburg Pincus LLC |
SELL
Open market or private sale
|
Indirect |
3,686,225
-41.09%
|
$184,311,250
$50.35 P/Share
|
|
Nov 15
2020
|
Steven S. Williamson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+49.25%
|
-
|
|
Sep 17
2020
|
Warburg Pincus LLC |
BUY
Conversion of derivative security
|
Indirect |
6,394,809
+41.62%
|
-
|